Bharat Serums and Vaccines would run as an independent business, says Mankind’s Rajeev Juneja
Days after Mankind Pharma inked a ₹13,630 crore deal to buy Bharat Serums and Vaccines (BSV), its top management said BSV would run as an independent business, reporting to the Mankind board. BSV presented itself as an attractive opportunity, not just as a …